🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the manufacturers of Tylenol, alleging the corporations concealed safety concerns that the drug presented to pediatric cognitive development.

The lawsuit follows thirty days after Former President Trump promoted an unsubstantiated connection between using acetaminophen - alternatively called acetaminophen - throughout gestation and autism spectrum disorder in children.

Paxton is suing the pharmaceutical giant, which previously sold the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which presently makes it.

In a official comment, he claimed they "deceived the public by gaining financially from discomfort and pushing pills regardless of the dangers."

Kenvue says there is lacking scientific proof connecting Tylenol to autism.

"These companies deceived for years, knowingly endangering millions to boost earnings," Paxton, a Republican, declared.

Kenvue stated officially that it was "very worried by the dissemination of inaccurate information on the reliability of paracetamol and the likely effects that could have on the health of US mothers and children."

On its website, the company also stated it had "continuously evaluated the relevant science and there is no credible data that indicates a established connection between taking paracetamol and autism."

Organizations representing doctors and medical practitioners concur.

The leading OB-GYN organization has said acetaminophen - the primary component in Tylenol - is a restricted selection for women during pregnancy to manage discomfort and fever, which can pose serious health risks if left untreated.

"In over twenty years of investigation on the consumption of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the usage of paracetamol in any period of gestation causes neurological conditions in offspring," the association commented.

The lawsuit cites latest statements from the Trump administration in arguing the medication is potentially dangerous.

Last month, the former president caused concern from health experts when he told pregnant women to "resist strongly" not to consume acetaminophen when sick.

The US Food and Drug Administration then published an announcement that medical professionals should contemplate reducing the consumption of acetaminophen, while also declaring that "a proven link" between the drug and autism spectrum disorder in children has remains unverified.

The Health Department head RFK Jr, who supervises the FDA, had pledged in spring to initiate "a massive testing and research effort" that would identify the cause of autism in a matter of months.

But authorities warned that identifying a unique factor of autism - considered by experts to be the result of a complicated interplay of genetic and external influences - would not be simple.

Autism is a category of enduring cognitive variation and disability that influences how persons encounter and relate to the world, and is diagnosed using physician assessments.

In his legal document, the attorney general - a Trump ally who is seeking US Senate - alleges Kenvue and Johnson & Johnson "deliberately disregarded and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the firms "destroy any marketing or advertising" that asserts Tylenol is reliable for women during pregnancy.

The court case parallels the complaints of a collection of parents of young ones with autism and ADHD who filed suit against the makers of Tylenol in recently.

The court rejected the lawsuit, declaring research from the plaintiffs' authorities was lacking definitive proof.